Navigation Links
Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
Date:11/7/2008

inical trials of

patients with cancer. A rate of hemoglobin rise of 1 g/dL over 2 weeks

may contribute to these risks.

-- Dose of PROCRIT

-- Chronic renal failure patients: The dose of PROCRIT should be titrated for each patient to achieve and maintain hemoglobin levels between 10 to 12 g/dL. If a patient does not attain hemoglobin levels of 10 to 12 g/dL despite 12 weeks of appropriate PROCRIT therapy, see DOSAGE and ADMINISTRATION in the PROCRIT Prescribing Information.

-- Cancer patients: PROCRIT therapy should not be initiated at hemoglobin levels greater than or equal to 10 g/dL. The dose of PROCRIT should be titrated for each patient to achieve and maintain the lowest hemoglobin level sufficient to avoid the need for blood transfusion. Discontinue if after 8 weeks of therapy there is no response as measured by hemoglobin levels or if transfusions are still required (see recommended Dose Modification section in DOSAGE and ADMINISTRATION of the PROCRIT Prescribing Information).

-- HIV patients: The dose of PROCRIT should be titrated for each patient to achieve and maintain the lowest hemoglobin level sufficient to avoid transfusion and not to exceed the upper safety limit of 12 g/dL.

-- Monitor hemoglobin regularly during therapy, weekly until hemoglobin

becomes stable.

-- Cases of pure red cell aplasia (PRCA) and of severe anemia, with or

without other cytopenias, associated with neutralizing antibodies to

erythropoietin have been reported in patients treated with PROCRIT;

predominantly in patients with chronic renal failure receiving PROCRIT

by subcutaneous administration. If any patient develops a sudden loss

of response to PROCRIT, accompanied by severe anemia and low

reticulocyte count, and anti-erythropoietin antibody-associated anemia

is suspected, withhold PROCRIT and other erythropoietic proteins.


'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
3. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
6. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
7. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
8. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Inivata, a Cambridge, England -based ... the 2015 American Association for Cancer Research (AACR) Annual Meeting ... and a poster presentation. Michael Stocum , CEO ... nd . The presentation, entitled Monitoring the ... part of a session on Recent Advances in Diagnostics ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) has announced ... Leasing - Global Strategic Business Report" report to ... markets for Medical Equipment Rental and Leasing in US$ ... US, Japan , Europe ... estimates and forecasts are provided for the period 2014 ...
(Date:4/17/2015)... 2015  Trovagene, Inc., (NASDAQ:  TROV) a developer ... data presented at the 2015 European Lung Cancer ... Monitoring ℠ (PCM) platform outperformed tissue biopsy ... T790M mutations in metastatic lung cancer patients. ... Mutation in Urinary Circulating Tumor DNA from Metastatic ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... 18 Novavax, Inc. (Nasdaq: NVAX ) a ... , President and Chief Executive Officer, will be presenting at ... 21 and June 22, 2010 at The ... in the roundtable discussion, , Getting ready for the next ...
... , June 17 Allied Healthcare Products, Inc. (Nasdaq: ... carbon dioxide absorbent that provides enhanced patient safety over conventional absorbents ... , ... commonly associated with conventional carbon dioxide absorbents, yet it has been ...
Cached Medicine Technology:Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010 2Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia 2
(Date:4/18/2015)... April 18, 2015 In the past ... couple of changes. , "We had to run maintenance ... needed changes," said Jennifer Ramirez, the PR Director. "It ... to say that we are back on track after ... the process of changing phone systems which has not ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 On April 14th, ... Threat Report , which they say, “exposes a tactical shift ... new malware variants were introduced in 2014 - almost a ... Zero Day threats to be identified and patched by prominent ... abundantly clear that doing business in a digital world can ...
(Date:4/18/2015)... 2015 “ ArcAngel ” was featured on ... look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... app. , In a turbulent world, people may find ... should always be their first move, but some situations can ...
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin ... he uttered, “Tell me what you eat, and I ... cope with stress or sadness has often been attributed ... otherwise. Data collected from their Emotional Eating Test ... eating, but for different reasons. , Collecting data from ...
(Date:4/17/2015)... John Evans, a Gardant affordable assisted ... from 2 p.m. to 3 p.m. on April 24. ... Ct. in Pekin, Illinois, serves older adults of all ... to maintain their independence. , Becky Baker will entertain ... be served during the luau. , For more information, ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2
... June 27, HIV Testing Day, the HIV Medicine Association (HIVMA) ... in linking people to lifesaving care and reducing the spread ... HIVMA calls on policymakers to do more to make every ... covers such screening as a standard part of routine medical ...
... 22 Epeius Biotechnologies ( www.epeiusbiotech.com ) ... demonstration of single-agent efficacy with its lead product, Rexin-G, ... of June 16, 2009 in Molecular Therapy, the Official ... www.nature.com/mt/ ) documents the results of two ...
... Lead Educational Underwriter , , WASHINGTON, June 22 ... Innovation and Technology Congress (WHIT 5.0), in conjunction with ... announces that President Bill Clinton will deliver a keynote ... 2009. , , President Clinton will join ...
... D.C., June 23, 2009 With millions of people in ... and our Canadian neighbors doing likewise for their July ... light shows of the future likely to ignite a smile ... fireworks is quietly making its way toward the sky. ...
... MapHIV.org Shows Vast Majority of Nation,s HIV Burden Clustered in ... The National Minority Quality Forum ... highlights the impact of the HIV/AIDS epidemic in communities across ... rates available in a single location for the first time, ...
... National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas , ... Minority Quality Forum today launched a groundbreaking HIV/AIDS Atlas ( ... of the HIV/AIDS epidemic in communities across the United States. ... in a single location for the first time, painting a ...
Cached Medicine News:Health News:On HIV Testing Day, HIVMA calls for health care reform to make testing routine every day 2Health News:Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival 2Health News:President Bill Clinton to Deliver Keynote Address at 5th Annual World Healthcare Innovation and Technology Congress, November 10, 2009, Washington, D.C. 2Health News:President Bill Clinton to Deliver Keynote Address at 5th Annual World Healthcare Innovation and Technology Congress, November 10, 2009, Washington, D.C. 3Health News:'Green' fireworks may brighten eco-friendly 4th of July displays in future 2Health News:Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas 2Health News:Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas 3Health News:MapHIV.org Shows Massachusetts' Suffolk County Seriously Impacted by HIV and AIDS 2Health News:MapHIV.org Shows Massachusetts' Suffolk County Seriously Impacted by HIV and AIDS 3
Enzyme Immunoassay for the quantitative ( qualitative 0020, on request) determination of IgG Class antibodies to Rubella virus....
Donor Screen & Confirmation Kit...
... antibody gives positive staining of prostatic ... hyperplasia. In cases of prostatic cancer, ... give definite but weak staining or ... cells; this pattern of staining permits ...
... a comprehensive line of pregnancy tests including ... in convenient one-step stick and cassette formats. ... Clearview Easy HCG is a 25 mIU ... Clearview HCG II provides 25mIU sensitivity ...
Medicine Products: